المؤلفون: John Wrangle, Ticiana Leal, Gilles Robinet, Neal Ready, David Maag, Jyoti Malhotra, Melissa Lynne Johnson, Satwant Lally, Petros Nikolinakos, Jyoti D. Patel, Daniel Morgensztern, Benjamin Besse, Vincent Blot, Giuseppe Curigliano, Ricardo Valenzuela, Laurent Greillier, Jonathan M. Lehman

المساهمون: Rutgers cancer institute of New Jersey [Newark, NJ], University Cancer and Blood Center (UCBC), University of Wisconsin-Madison, Vanderbilt University Medical Center [Nashville], Vanderbilt University [Nashville], Washington University School of Medicine in St. Louis, Washington University in Saint Louis (WUSTL), Feinberg School of Medicine, Northwestern University [Evanston], Medical University of South Carolina [Charleston] (MUSC), Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Méthodes computationnelles pour la prise en charge thérapeutique en oncologie : Optimisation des stratégies par modélisation mécaniste et statistique (COMPO), Inria Sophia Antipolis - Méditerranée (CRISAM), Institut National de Recherche en Informatique et en Automatique (Inria)-Institut National de Recherche en Informatique et en Automatique (Inria)-Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Sarah Cannon Research Institute [Nashville, Tennessee], Duke University Medical Center, Hôpital Morvan - CHRU de Brest (CHU - BREST ), Abbvie Inc. [North Chicago], Institut Gustave Roussy (IGR), Université Paris-Saclay, Département de médecine oncologique [Gustave Roussy]

المصدر: Journal of Thoracic Oncology
Journal of Thoracic Oncology, 2021, 16 (9), pp.1559-1569. ⟨10.1016/j.jtho.2021.02.022⟩

مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Immunoconjugates, Lung Neoplasms, Combination therapy, [SDV.CAN]Life Sciences [q-bio]/Cancer, Ipilimumab, Antibodies, Monoclonal, Humanized, [SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, Gastroenterology, MESH: Benzodiazepinones, MESH: Ipilimumab, 03 medical and health sciences, Clinical trials, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, MESH: Immunoconjugates, medicine, Humans, Antibody-drug conjugates, Adverse effect, Benzodiazepinones, MESH: Humans, business.industry, Rovalpituzumab tesirine, respiratory tract diseases, MESH: Lung Neoplasms, MESH: Antineoplastic Combined Chemotherapy Protocols, Nivolumab, 030104 developmental biology, Oncology, Tolerability, MESH: Antibodies, Monoclonal, Humanized, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, Cohort, Small-molecule agents, MESH: Nivolumab, [SDV.IMM]Life Sciences [q-bio]/Immunology, Immunotherapy, Lung cancer, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7c2323534cecd409bf8ef57951bfa24Test
https://doi.org/10.1016/j.jtho.2021.02.022Test

المؤلفون: Francesco Facchinetti, Antonin Levy, Pernelle Lavaud, David Planchard, Samy Ammari, Benjamin Besse, C. Naltet, D. Vasseur, Mihaela Aldea

المصدر: Cancer Management and Research

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Disease Response, medicine.medical_treatment, brain, Entrectinib, Case Report, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, tyrosine kinase inhibitors, medicine, ROS1, Lung cancer, radiotherapy, Crizotinib, business.industry, medicine.disease, central nervous system, Lorlatinib, TKI, Radiation therapy, lung cancer, 030104 developmental biology, Meningeal carcinomatosis, 030220 oncology & carcinogenesis, CNS, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32656c78bea67504fce7adab008c319bTest
http://europepmc.org/articles/PMC8009349Test

المؤلفون: Yohann Loriot, Celine Mahier Ait Oukhatar, Benjamin Besse, S. Ortiz-Cuaran, Washington René Chumbi Flores, Jean-Yves Blay, Etienne Giroux Leprieur, Ludovic Lacroix, Mihaela Aldea, Claire Tissot, Clive Morris, Caroline Caramella, Julien Mazieres, Radj Gervais, Karen Howarth, Maurice Perol, Emma Green, Pierre Saintigny, Isabelle Monnet, C. Raynaud, Virginie Westeel, V. Avrillon, Etienne Brain, Jean-François Guichou, Camille Leonce, Maud Ngo-Camus, Anne Pradines, Frank de Kievit, Laura Mezquita, Sylvie Chabaud, Aurélie Swalduz, Cécile Jovelet, David Planchard, Luc Friboulet, N. Hoog-Labouret

المصدر: Clinical Cancer Research

مصطلحات موضوعية: 0301 basic medicine, MAPK/ERK pathway, Cancer Research, IDH1, endocrine system diseases, Combination therapy, In silico, 03 medical and health sciences, 0302 clinical medicine, Medicine, skin and connective tissue diseases, Lung cancer, Prospective cohort study, neoplasms, PI3K/AKT/mTOR pathway, Kinase, business.industry, medicine.disease, digestive system diseases, 3. Good health, enzymes and coenzymes (carbohydrates), 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Cancer research, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a08e5770bf7df9029b5cbadf8cc90a2Test
https://doi.org/10.1158/1078-0432.ccr-20-1037Test

المؤلفون: Jose Carlos Benitez, Benjamin Besse, Jordi Remon

المصدر: Clinical Cancer Research. 26:5068-5077

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Immune checkpoint inhibitors, Breast Neoplasms, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Immune system, Cancer immunotherapy, Carcinoma, Non-Small-Cell Lung, Internal medicine, polycyclic compounds, medicine, Humans, Immune Checkpoint Inhibitors, Melanoma, Bladder cancer, business.industry, Cancer, medicine.disease, Neoadjuvant Therapy, 030104 developmental biology, Urinary Bladder Neoplasms, 030220 oncology & carcinogenesis, Cancer cell, Female, Immunotherapy, business, Adjuvant, hormones, hormone substitutes, and hormone antagonists

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::240405d412cbc4748c8256286dc2d755Test
https://doi.org/10.1158/1078-0432.ccr-19-3255Test

المؤلفون: Alexis B. Cortot, Sébastien Couraud, M. van den Heuvel, Julie Milia, Benjamin Besse, S-H.I. Ou, Sacha I. Rothschild, Mickaël Lattuca-Truc, Laura Mezquita, Joel W. Neal, Rafael Rosell, Amélie Lusque, R.D. Schouten, Terry L. Ng, Martin Früh, Marcel Wiesweg, Benjamin Solomon, D.R. Camidge, Nir Peled, C. Mascaux, Gérard Zalcman, Alexander Drilon, Alessandra Curioni-Fontecedro, Heather A. Wakelee, Alex Martinez-Marti, Paolo Bironzo, Julien Mazieres, Sanjay Popat, Valérie Gounant, Laurent Mhanna, Remi Veillon, Viola W. Zhu, Oliver Gautschi, Fabrice Barlesi, Joshua K. Sabari, Silvia Novello, A. Thai, Joachim Diebold

المساهمون: Rangueil-Larrey University Hospital, Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Service de pneumologie [Centre Hospitalier Lyon Sud - HCL], Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Intergroupe Francophone de Cancérologie Thoracique [Paris] (IFCT), Intergroupe Francophone de Cancérologie thoracique, Service d'oncologie multidisciplinaire innovations thérapeutiques [Hôpital Nord - APHM], Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital Nord [CHU - APHM], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)

المصدر: Annals of Oncology
Annals of Oncology, Elsevier, 2019, 30 (8), pp.1321-1328. ⟨10.1093/annonc/mdz167⟩
Annals of oncology : official journal of the European Society for Medical Oncology, vol 30, iss 8
Annals of Oncology, 30, 8, pp. 1321-1328
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Annals of Oncology, 30, 1321-1328
Annals of Oncology, 2019, 30 (8), pp.1321-1328. ⟨10.1093/annonc/mdz167⟩
Translational Cancer Research

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Lung Neoplasms, [SDV]Life Sciences [q-bio], Programmed Cell Death 1 Receptor, Medizin, medicine.disease_cause, B7-H1 Antigen, Antineoplastic Agents, Immunological, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Registries, Non-Small-Cell Lung, Lung, Cancer, Aged, 80 and over, Tumor, Hematology, Middle Aged, Chemotherapy regimen, Progression-Free Survival, 3. Good health, Immunotherapy-lung cancer-oncogenic addiction, Editorial Commentary, Immunological, Response Evaluation Criteria in Solid Tumors, 5.1 Pharmaceuticals, 030220 oncology & carcinogenesis, Adenocarcinoma, Female, KRAS, immunotherapy, Development of treatments and therapeutic interventions, hormones, hormone substitutes, and hormone antagonists, Adult, medicine.medical_specialty, Clinical Trials and Supportive Activities, Oncology and Carcinogenesis, Context (language use), Antineoplastic Agents, and over, [SDV.BC]Life Sciences [q-bio]/Cellular Biology, Rare cancers Radboud Institute for Molecular Life Sciences [Radboudumc 9], 03 medical and health sciences, Clinical Research, Internal medicine, Biomarkers, Tumor, medicine, ROS1, Humans, Progression-free survival, Oncology & Carcinogenesis, Lung cancer, oncogenic addiction, neoplasms, Retrospective Studies, Aged, Thoracic tumor, business.industry, Carcinoma, Oncogenes, medicine.disease, respiratory tract diseases, lung cancer, 030104 developmental biology, Good Health and Well Being, Mutation, business, Biomarkers

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e867e14cd0d6a70a74a91dd0f799916bTest
http://europepmc.org/articles/PMC7389252Test

المؤلفون: Jordi Remon, Aurélie Honoré, Françoise Farace, Pauline Queffelec, Maud Ngo-Camus, Vincent Faugeroux, David Planchard, Emma Pailler, Ludovic Lacroix, Luc Friboulet, Marianne Oulhen, Benjamin Besse, Mélanie Laporte, Yann Lécluse, Laura Mezquita, Claudio Nicotra

المصدر: Clinical Cancer Research

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Crizotinib, business.industry, Genetic heterogeneity, Drug resistance, Gene rearrangement, medicine.disease, Lorlatinib, 3. Good health, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Circulating tumor cell, Oncology, hemic and lymphatic diseases, 030220 oncology & carcinogenesis, Cancer research, Medicine, Anaplastic lymphoma kinase, business, Lung cancer, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::112e7e71735d9e90646f4b54e7c4313eTest
https://doi.org/10.1158/1078-0432.ccr-19-1176Test

المؤلفون: Ludovic Lacroix, Benjamin Besse, Michèle Beau-Faller, Pamela Biondani, Lizza E.L. Hendriks, Pernelle Lavaud, Julien Adam, Anas Gazzah, Charlotte Leduc, Jordi Remon, Emilie Le Rhun, Ronan Flippot, Caroline Caramella, C. Naltet, David Planchard, Radj Gervais, Cécile Le Péchoux, Laura Mezquita, Dingyu Xiao, Edouard Auclin

المساهمون: Département d'hématologie [Gustave Roussy], Institut Gustave Roussy (IGR), Centre Régional de Lutte contre le Cancer François Baclesse [Caen] (UNICANCER/CRLC), UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU), School for Oncology and Developmental Biology [Maastricht] (GROW), Maastricht University [Maastricht]-Maastricht University Medical Centre (MUMC), Maastricht University [Maastricht], University of Lille, Department of Radiology, CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Department of Radiotherapy, Pulmonologie, Promovendi ODB, MUMC+: MA Med Staf Spec Longziekten (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Département de médecine oncologique [Gustave Roussy], Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Département de biologie et pathologie médicales [Gustave Roussy], Département d’Innovation Thérapeutique et essais précoces [Gustave Roussy] (DITEP)

المصدر: Journal of Thoracic Oncology
Journal of Thoracic Oncology, Lippincott, Williams & Wilkins, 2019, 14, pp.1400-1407. ⟨10.1016/j.jtho.2019.05.007⟩
Journal of Thoracic Oncology, 14(8), 1400-1407. Elsevier Science
Journal of Thoracic Oncology, 2019, 14, pp.1400-1407. ⟨10.1016/j.jtho.2019.05.007⟩

مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, Male, medicine.medical_specialty, Lung Neoplasms, medicine.drug_class, Afatinib, [SDV]Life Sciences [q-bio], EGFR, CELL LUNG-CANCER, BRAIN METASTASES, Tyrosine kinase inhibitor, NSCLC, Tyrosine-kinase inhibitor, 03 medical and health sciences, 0302 clinical medicine, Gefitinib, Refractory, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Humans, Osimertinib, Dosing, Protein Kinase Inhibitors, Retrospective Studies, Leptomeningeal metastases, business.industry, Retrospective cohort study, Middle Aged, Survival Analysis, respiratory tract diseases, 3. Good health, ErbB Receptors, 030104 developmental biology, Treatment Outcome, DOSE WEEKLY ERLOTINIB, 030220 oncology & carcinogenesis, Mutation, Female, Erlotinib, business, Meningeal Carcinomatosis, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::511ce6023917bed9c979e64c0a2db523Test
https://doi.org/10.1016/j.jtho.2019.05.007Test

المؤلفون: Patricia Martin-Romano, H. Oliveres, Cristina Smolenschi, Lydia Gaba, P. Vuagnat, Jorge Adeva, Eduardo Castanon, Yola El Dakdouki, Laetitia Nebot-Bral, Rocio Garcia-Carbonero, Benjamin Besse, Marta Garcia de Herreros, Federico Longo-Muñoz, Tamara Sauri, Rosario Vidal Tocino, Edouard Auclin, Julien Taieb, Antoine Hollebecque, Laura Mezquita, Christophe Massard

المصدر: Cancers, Vol 13, Iss 3776, p 3776 (2021)
Cancers
Volume 13
Issue 15

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, medicine.medical_specialty, LDH, medicine.medical_treatment, LIPI, Gastroenterology, Article, immune checkpoint inhibitors, 03 medical and health sciences, 0302 clinical medicine, Immune system, Refractory, Internal medicine, medicine, Clinical endpoint, dMMR, RC254-282, Predictive marker, Lung, Performance status, business.industry, MSI-H, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Retrospective cohort study, Immunotherapy, 030104 developmental biology, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, dNLR, immunotherapy, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3d8359793954215378670b8aff62b88Test
https://www.mdpi.com/2072-6694/13/15/3776Test

المؤلفون: Benjamin Besse, Laura Mezquita, Edouard Auclin

المصدر: Cancers
Cancers, Vol 13, Iss 3624, p 3624 (2021)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Combination therapy, Subgroup analysis, 03 medical and health sciences, 0302 clinical medicine, Immune system, Atezolizumab, Internal medicine, medicine, In patient, Lung cancer, RC254-282, Lung, business.industry, Comment, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, n/a, 030104 developmental biology, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Non small cell, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc694a6d19c6a159563195fcc8bf2ba3Test
http://europepmc.org/articles/PMC8307040Test

المؤلفون: Fabiola Fernandez-Gutierrez, Caroline Dive, Alessandro Morabito, T. Jeroen N. Hiltermann, Colin R Lindsay, Benjamin Besse, Fiona H Blackhall, Harry J.M. Groen, Francesco Perrone, Françoise Farace, Nicola Normanno, Victoria Foy, Andrew G Renehan, Mathew Carter, Matthew G Krebs, Lynsey Priest, Leon W.M.M. Terstappen, Alexandra Carmel, Corinne Faivre-Finn, Elisabetta Rossi, Stefan Michiels, Antonella De Luca

المساهمون: TechMed Centre, Medical Cell Biophysics, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Translational Immunology Groningen (TRIGR)

المصدر: Foy, V, Lindsay, C R, Carmel, A, Fernandez-Gutierrez, F, Krebs, M G, Priest, L, Carter, M, Groen, H J M, Hiltermann, T J N, de Luca, A, Farace, F, Besse, B, Terstappen, L, Rossi, E, Morabito, A, Perrone, F, Renehan, A, Faivre-Finn, C, Normanno, N, Dive, C, Blackhall, F & Michiels, S 2021, ' EPAC-lung : European pooled analysis of the prognostic value of circulating tumour cells in small cell lung cancer ', Translational Lung Cancer Research, vol. 10, no. 4, pp. 1653-1665 . https://doi.org/10.21037/tlcr-20-1061Test
Translational Lung Cancer Research, 10(4), 1653-1665. Society for Translational Medicine (STM)
Translational lung cancer research, 10(4), 1653-1665. AME PUBL CO
Transl Lung Cancer Res

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Prognostic models, IMPACT, education, PERIPHERAL-BLOOD, THERAPY, Liquid biopsies, INTERNATIONAL ASSOCIATION, 03 medical and health sciences, 0302 clinical medicine, METASTATIC BREAST-CANCER, Internal medicine, medicine, PROGRESSION-FREE, Progression-free survival, Lung cancer, neoplasms, EDITION, Lung, Manchester Cancer Research Centre, business.industry, Proportional hazards model, ResearchInstitutes_Networks_Beacons/mcrc, Hazard ratio, Cancer, TNM CLASSIFICATION, Biomarker, Small cell lung cancer (SCLC), medicine.disease, Meta-analysis, 030104 developmental biology, medicine.anatomical_structure, 030220 oncology & carcinogenesis, SURVIVAL, Biomarker (medicine), Original Article, business, Circulating tumour cells (CTCs), PROPOSALS

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f509aaeef7492549a632754ed75925f2Test
https://doi.org/10.21037/tlcr-20-1061Test